CHOP Clinical Trials

1 recruitingLast updated: May 5, 2026

There are 67 actively recruiting chop clinical trials across 23 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1. Top locations include Jinan, Shandong, China, Kansas City, Missouri, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


CHOP Trials at a Glance

67 actively recruiting trials for chop are listed on ClinicalTrialsFinder across 6 cities in 23 countries. The largest study group is Not Applicable with 28 trials, with the heaviest enrollment activity in Jinan, Kansas City, and Boston. Lead sponsors running chop studies include Qianfoshan Hospital, University of Alabama at Birmingham, and Children's Hospital of Philadelphia.

Browse chop trials by phase

Treatments under study

About CHOP Clinical Trials

Looking for clinical trials for CHOP? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new CHOP trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about CHOP clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 67 trials

Recruiting
Not Applicable

Cereset Research Exploratory Study

Neurological Diseases or ConditionsCardiovascular Conditions After BirthPsychophysiologic Disorders
Wake Forest University Health Sciences200 enrolled1 locationNCT03777267
Recruiting
Not Applicable

Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC

Pulmonary HypertensionBPD - Bronchopulmonary DysplasiaNEC
The Hospital for Sick Children36 enrolled1 locationNCT05636397
Recruiting
Phase 2

Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below

Bronchopulmonary Dysplasia
International Peace Maternity and Child Health Hospital29 enrolled1 locationNCT07561125
Recruiting
Not Applicable

Stanford Program to Accelerate Robotic Children's Surgery

EndometriosisCholecystectomyHysterectomy+16 more
Stanford University250 enrolled1 locationNCT06671639
Recruiting
Not Applicable

An Evidence-based Family Support Program for Parents and Children in Palestine: A Theory-based Intervention

PsychopathologyAdolescentViolence+1 more
University of Notre Dame900 enrolled1 locationNCT05706376
Recruiting

Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary AspergillosisSevere AsthmaABPA
Qianfoshan Hospital20 enrolled2 locationsNCT07530770
Recruiting

A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

Allergic Bronchopulmonary AspergillosisEfficacy and SafetyABPA+3 more
Qianfoshan Hospital50 enrolled1 locationNCT07362693
Recruiting
Not Applicable

Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease

PsychologicalStressEmotions+3 more
Bryan Denny270 enrolled1 locationNCT05949047
Recruiting
Not Applicable

Oral Itraconazole Versus Combination of Systemic Glucorticoids and Oral Itraconazole in CPA-ABPA Overlap Syndrome

Allergic Bronchopulmonary AspergillosisChronic Pulmonary Aspergillosis
Post Graduate Institute of Medical Education and Research, Chandigarh104 enrolled2 locationsNCT05444946
Recruiting

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

Heart FailurePainInsomnia+22 more
Duke University5,000 enrolled51 locationsNCT04278404
Recruiting
Phase 2

IVIG Trial for the Treatment of Bronchopulmonary Dysplasia

Bronchopulmonary Dysplasia
International Peace Maternity and Child Health Hospital20 enrolled1 locationNCT06925360
Recruiting
Phase 1

Inhaled Ciclesonide Study in Preterm Infants

Bronchopulmonary Dysplasia
Venkatesh Sampath30 enrolled1 locationNCT06589245
Recruiting
Not Applicable

Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

Pulmonary HypertensionBronchopulmonary Dysplasia
University of Alabama at Birmingham39 enrolled2 locationsNCT06373289
Recruiting

Immune Status and Disease Control of Inflammatory Airway Diseases

Airway inflammationChronic Obstructive Pulmonary Disease (COPD)Bronchiectasis+3 more
First Affiliated Hospital of Ningbo University200 enrolled1 locationNCT07493629
Recruiting
Phase 1Phase 2

PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia

Critical IllnessBronchopulmonary Dysplasia (BPD)Premature Births
Duke University28 enrolled4 locationsNCT07101640
Recruiting

Pressure-Sensing Mattresses and Mechanical Ventilation Weaning in Neonatal

Bronchopulmonary Dysplasia
Fu Jen Catholic University60 enrolled1 locationNCT06579157
Recruiting

Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome

Genetic DiseaseChopra-Amiel-Gordon SyndromeCAGS+1 more
Boston Children's Hospital125 enrolled1 locationNCT05528744
Recruiting
Phase 2Phase 3

Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)

Bronchopulmonary Dysplasia
Airway Therapeutics, Inc.366 enrolled20 locationsNCT06897839
Recruiting

National Surveillance and Prevention of Neonatal VAP

Bronchopulmonary Dysplasia (BPD)Ventilator-Associated Pneumonia (VAP), NeonatalAntibiotic-Resistant Organisms (AROs)+1 more
University of Alberta1,500 enrolled1 locationNCT07109791
Recruiting
Not Applicable

The Effects of Transcranial Current Stimulation on Insomnia

Insomnia, Psychophysiological
Zan Wang100 enrolled2 locationsNCT07340268